EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Efficacy of Topical Betamethasone Valerate and Olive Oil in Preventing Acute Radiation Dermatitis in Breast Cancer: A Randomized Double-Blind Placebo-Controlled Study

Israa K Mohamed, Maggie M Abbassi, Mohamed R Kelany, Samar F Farid

Clinical Breast Cancer · 2026

DOI: 10.1016/j.clbc.2025.08.008 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Breast Cancer, 2026. Verfasst von Israa K Mohamed und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt. Electronic address: esraa.kamal@pharma.cu.edu.eg. Hauptthemen laut MEDLINE: Olive Oil, Breast Neoplasms, Radiodermatitis, Betamethasone Valerate. Die Arbeit nennt 55 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIM: The purpose of this study is to compare topical betamethasone-17-valerate and olive oil cream in preventing radiation-induced dermatitis (RID) in breast cancer patients and to provide prospective data evaluating the quality of life, subjective symptoms, and treatment satisfaction reported by the patients. METHODS: This was a prospective, double-blind, randomized, parallel, placebo-controlled trial. A total of 132 patients were randomized into three groups to receive either olive oil cream (G1), betamethasone-17-valerate (Betnovate® cream, GlaxoSmithKline) (G2), or unmedicated cream base (G3) throughout radiotherapy (RT) and 2 weeks after. The study is registered on clinicaltrials.gov with ID: NCT05285943, Date: November 2021. RESULTS: A total of 128 patients were included in the final analysis. Betamethasone and olive oil significantly differed from the unmedicated cream base at weeks 1 to 4 (P 0.999). Furthermore, the percentage of patients who developed grade 3 at the end of the follow-up was significantly different between the olive oil group and the unmedicated cream base group (27.9% vs. 61%, P = 0.004). Additionally, olive oil and betamethasone had non-significant delayed grade 2 and grade 3 development (P > 0.999). CONCLUSION: Olive oil cream is as effective as betamethasone in alleviating RID in patients treated with adjuvant radiotherapy for breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Olive OilBreast NeoplasmsRadiodermatitisBetamethasone ValerateHumansFemaleDouble-Blind MethodMiddle AgedProspective StudiesAgedAdultQuality of LifeAdministration, TopicalTreatment Outcome

Stichwörter der Autor:innen

CorticosteroidNatural agentPatient-reported outcomesRadiation-induced dermatitisTopical agent

Substanzen

Olive OilBetamethasone Valerate

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt. Electronic address: esraa.kamal@pharma.cu.edu.eg.
  • Department of Clinical Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
  • Department of Clinical Oncology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

Zitieren

APA

Mohamed, I. K., Abbassi, M. M., Kelany, M. R., & Farid, S. F. (2026). Efficacy of Topical Betamethasone Valerate and Olive Oil in Preventing Acute Radiation Dermatitis in Breast Cancer: A Randomized Double-Blind Placebo-Controlled Study. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2025.08.008

Vancouver

Mohamed IK, Abbassi MM, Kelany MR, Farid SF. Efficacy of Topical Betamethasone Valerate and Olive Oil in Preventing Acute Radiation Dermatitis in Breast Cancer: A Randomized Double-Blind Placebo-Controlled Study. Clinical Breast Cancer. 2026. doi:10.1016/j.clbc.2025.08.008

BibTeX
@article{Mohamed2026,
  author = {Mohamed, Israa K and Abbassi, Maggie M and Kelany, Mohamed R and Farid, Samar F},
  title = {Efficacy of Topical Betamethasone Valerate and Olive Oil in Preventing Acute Radiation Dermatitis in Breast Cancer: A Randomized Double-Blind Placebo-Controlled Study},
  journal = {Clinical Breast Cancer},
  year = {2026},
  doi = {10.1016/j.clbc.2025.08.008}
}
Kostenlos starten →